Table 1.

Determinants of AKI-D outcomes.

Determinants of AKI-D Outcomes
•  Demographics and Co-morbidities
•        Patient demographics
•        Co-morbidities
•             Severity of acute disease
•             Pre-existing CKD
•             Prior AKI
•             Diabetes Mellitus
•             Cardio-vascular diseases
•             Volume overload
•             Other co-morbidities: Chronic liver diseases, cancer, surgeries.
•    Laboratory parameters
•    Medications
•         Renin Angiotensin Inhibitors (RASi):
•         Diuretics
•         Pressors
•    Outpatient care of Patients with AKI-D
•         Dialysis-Related Factors
•              Renal Replacement Modality
•              Dose and Duration of RRT
•              Intradialytic Hypotensive Episodes
•         Nephrology follow up post AKI
•    Biomarkers
•         uCCL-14
•         uNGAL/Creatinine ratio
•         uGM2AP
•         uTCP1-eta

Abbreviations: uCCL-14: urinary C-C motif chemokine ligand 14, uNGAL: urinary Neutrophil gelatinase-associated lipocalin, uGM2AP: urinary Ganglioside M2 activator protein, uTCP1-eta: tail-less complex polypeptide-1 eta subunit.